CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-27 | Kuhlmann Shirley R. EVP and General Counsel | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −25,600 | 0 | ||
| 2023-06-26 | Kuhlmann Shirley R. EVP and General Counsel | Sale 10b5-1 | −16,621 | $21.65 | $360K | 120,881 |
| 2023-06-26 | Kuhlmann Shirley R. EVP and General Counsel | Sale 10b5-1 | −1,363 | $22.53 | $31K | 119,518 |
| 2023-06-02 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −30,272 | $21.58 | $653K | 276,000 |
| 2023-06-02 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −1,000 | $22.25 | $22K | 275,000 |
| 2023-06-01 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −31,272 | $22.09 | $691K | 306,272 |
| 2023-05-31 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −31,272 | $21.87 | $684K | 337,544 |
| 2023-05-30 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −31,271 | $21.90 | $685K | 368,816 |
| 2023-05-18 | Balice-Gordon Rita J. Director | Grant or award | +9,792 | 38,795 | ||
| 2023-05-18 | McFarlane Neil F. Director | Grant or award | +9,792 | 41,672 | ||
| 2023-05-18 | Heffernan Michael Thomas Director | Grant or award | +9,792 | 37,815 | ||
| 2023-05-18 | Freund John Gordon Director | Grant or award | +9,792 | 44,775 | ||
| 2023-05-18 | Fallon John A. Director | Grant or award | +9,792 | 47,150 | ||
| 2023-05-18 | Melincoff Gwen A Director | Grant or award | +9,792 | 44,775 | ||
| 2023-05-18 | SANTINI GINO Director | Grant or award | +9,792 | 67,963 | ||
| 2023-05-18 | BOHLIN GAREN G Director | Grant or award | +9,792 | 44,775 | ||
| 2023-03-15 | Tupper Colleen EVP & Chief Financial Officer | Sale | −31,640 | $23.77 | $752K | 105,420 |
| 2023-03-01 | Dreyer Scott EVP & Chief Commercial Officer | Sale | −13,324 | $26.70 | $356K | 134,882 |
| 2023-02-13 | Kuhlmann Shirley R. EVP and General Counsel | Sale | −21,811 | $26.88 | $586K | 137,502 |
| 2023-02-13 | Ciaffoni Joseph President and CEO | Option exercise | +11,250 | $15.90 | $179K | 411,337 |
Page 10 of 24 · 462 trades